CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...

Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading ...

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...

Piper Sandler named UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) as its top picks in the managed care space, arguing ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

CVS faces strong competition from Amazon, Walmart, and Costco, impacting market share. Read why I maintain a Hold rating for ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

We recently published a list of 10 Hottest Large-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

CVS Health (NYSE: CVS) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...

Explore the ongoing CVS Health stock performance and what to expect in the next few months as investors watch the ongoing ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...